Departments of Psychiatry and Cellular and Molecular Pharmacology, University of California, San Francisco School of Medicine, San Francisco, California (D.J., M.v.Z.); Drug Discovery Biology Theme, Monash Institute of Pharmaceutical Sciences, Monash University, Melbourne, Victoria, Australia (A.B.G.); Division of Physiology, Pharmacology and Neuroscience, School of Life Sciences, Queen's Medical Centre, University of Nottingham, Nottingham, United Kingdom (M.C.); and Centre of Membrane Protein and Receptors, Universities of Birmingham and Nottingham, The Midlands, United Kingdom (M.C.).
Departments of Psychiatry and Cellular and Molecular Pharmacology, University of California, San Francisco School of Medicine, San Francisco, California (D.J., M.v.Z.); Drug Discovery Biology Theme, Monash Institute of Pharmaceutical Sciences, Monash University, Melbourne, Victoria, Australia (A.B.G.); Division of Physiology, Pharmacology and Neuroscience, School of Life Sciences, Queen's Medical Centre, University of Nottingham, Nottingham, United Kingdom (M.C.); and Centre of Membrane Protein and Receptors, Universities of Birmingham and Nottingham, The Midlands, United Kingdom (M.C.)
Mol Pharmacol. 2020 Oct;98(4):425-432. doi: 10.1124/mol.119.119321. Epub 2020 Mar 20.
The powerful analgesic effects of opioid drugs have captivated the interest of physicians and scientists for millennia, and the ability of opioid drugs to produce serious undesired effects has been recognized for a similar period of time (Kieffer and Evans, 2009). Many of these develop progressively with prolonged or repeated drug use and then persist, motivating particular interest in understanding how opioid drugs initiate adaptive or maladaptive modifications in neural function or regulation. Exciting advances have been made over the past several years in elucidating drug-induced changes at molecular, cellular, and physiologic scales of analysis. The present review will highlight some recent cellular studies that we believe bridge across scales and will focus on optical imaging approaches that put opioid drug action "under the microscope." SIGNIFICANCE STATEMENT: Opioid receptors are major pharmacological targets, but their signaling at the cellular level results from a complex interplay between pharmacology, regulation, subcellular localization, and membrane trafficking. This minireview discusses recent advances in understanding the cellular biology of opioid receptors, emphasizing particular topics discussed at the 50th anniversary of the International Narcotics Research Conference. Our goal is to highlight distinct signaling and regulatory properties emerging from the cellular biology of opioid receptors and discuss potential relevance to therapeutics.
阿片类药物强大的镇痛效果引起了医生和科学家们数千年来的兴趣,而阿片类药物产生严重不良影响的能力也在相似的时间内得到了认识(Kieffer 和 Evans,2009)。其中许多副作用会随着药物使用时间的延长或重复使用而逐渐出现,并持续存在,这促使人们特别关注理解阿片类药物如何引发神经功能或调节的适应性或失调性改变。在过去几年中,在阐明药物在分子、细胞和生理分析尺度上引起的变化方面取得了令人兴奋的进展。本综述将重点介绍一些我们认为跨越多个尺度的最近的细胞研究,并重点介绍将阿片类药物作用“置于显微镜下”的光学成像方法。意义陈述:阿片受体是主要的药理学靶点,但它们在细胞水平的信号转导是药理学、调节、亚细胞定位和膜转运之间复杂相互作用的结果。这篇小综述讨论了理解阿片受体细胞生物学的最新进展,强调了在国际麻醉品研究会议 50 周年之际讨论的特定主题。我们的目标是突出阿片受体细胞生物学中出现的不同信号转导和调节特性,并讨论其对治疗的潜在相关性。